RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
44.83
-0.22 (-0.49%)
Nov 22, 2024, 4:00 PM EST - Market closed
RxSight Revenue
RxSight had revenue of $35.31M in the quarter ending September 30, 2024, with 59.08% growth. This brings the company's revenue in the last twelve months to $128.29M, up 67.52% year-over-year. In the year 2023, RxSight had annual revenue of $89.08M with 81.77% growth.
Revenue (ttm)
$128.29M
Revenue Growth
+67.52%
P/S Ratio
13.20
Revenue / Employee
$343,029
Employees
374
Market Cap
1.81B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Teladoc Health | 2.59B |
Integra LifeSciences Holdings | 1.56B |
Evotec SE | 866.67M |
GoodRx Holdings | 790.39M |
Harmony Biosciences Holdings | 681.88M |
NovoCure | 577.74M |
Arvinas | 161.10M |
Tarsus Pharmaceuticals | 129.62M |
RXST News
- 14 days ago - RxSight, Inc. (RXST) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024 - GlobeNewsWire
- 3 months ago - RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences - GlobeNewsWire
- 3 months ago - Investing In The Future Of Cataract Surgery: The RxSight Advantage - Seeking Alpha
- 3 months ago - RxSight, Inc. (RXST) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - RxSight, Inc. Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 4 months ago - RxSight, Inc. to Report Second Quarter Financial Results on August 5, 2024 - GlobeNewsWire
- 6 months ago - RxSight, Inc. To Participate in the Truist Securities Medtech Conference - GlobeNewsWire